# MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy

> **NCT01122524** · — · COMPLETED · sponsor: **Verinata Health, Inc.** · enrollment: 10000 (estimated)

## Conditions studied

- Pregnant Women
- Prenatal Care

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01122524
- **Lead sponsor:** Verinata Health, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2011-09
- **Final completion:** 2011-10
- **Target enrollment:** 10000 (ESTIMATED)
- **Last updated:** 2011-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01122524

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01122524, "MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT01122524. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*